should you eat before taking glp 1 How to Well and Feel Your Best on GLP-1 Medications How to eat if you

Agarwal R, Filippatos G, Pitt B, et al

Nutrients 10(11):1614

Based on these data, the FDA approved tesamorelin (marketed as EGRIFTA) for the reduction of excess abdominal fat in HIVassociated lipodystrophy, not as a general weightloss drug for the wider population. Tesamorelin Risks and Considerations Like all hormonemodulating therapies, tesamorelin carries potential risks, including fluid retention, joint pain, injectionsite reactions, and effects on glucose metabolism in susceptible patients

By engaging three metabolic pathways, it represents the next generation of weight management therapies with the potential for greater efficacy in both weight loss and metabolic improvement

Another level of complexity is added by the introduction of international units (IU)